INSIGHTS | oncologystrategies

Oncology leads the way in drug development across all therapeutic areas

PhRMA released its "Pharmaceutical Pipeline Report" today. Not too surprising to see all the activity in oncology. But almost a third of...

Oncology Strategies at Inaugural ASCO-SITC Clinical Immuno-Oncology Symposium - February 22-25, 2017

Cancer immunotherapy has resulted in considerable excitement in the oncology healthcare community. Over the last five years or so, we...

Coming Soon

“Innovative Insights are our specialty…stay tuned for our blog!”

Women often encountered the "broken rung" along their career journey. What is your experie

Women often encountered the "broken rung" along their career journey. What is your experience?

More I-O targets mean more shots on goal.

New Report Available from ACS: Progress in Global Cancer Fight is not only Possible, but Achievable

Breast Cancer Awareness Month begins today and I honor you!

Great progress in cancer drug development and approvals but still incredible unmet need.

How long should an office visit be? Is 20 minutes enough? Can you call that patient-centric care?

Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit

Top 20 Drugs of 2018 from Fierce Pharma

IQVIA report outlines key 2018 approvals and more